Phoenix Life Sciences International Limited. Debt Conversion, Converted Instrument, Amount
Phoenix Life Sciences International Limited. reported Debt Conversion, Converted Instrument, Amount of $5.28 thousand for the 9-month period ending 2018-11-30, per its 10-Q filed 2019-05-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2019-05-24
- Phoenix Life Sciences International Limited. debt conversion, converted instrument, amount for the quarter ending 2018-11-30 was $0.00.
- Phoenix Life Sciences International Limited. debt conversion, converted instrument, amount for the quarter ending 2018-08-31 was $0.00.
- Phoenix Life Sciences International Limited. debt conversion, converted instrument, amount for the quarter ending 2018-05-31 was $5.28K.
- Phoenix Life Sciences International Limited. debt conversion, converted instrument, amount for the quarter ending 2017-02-28 was $0.00, a 100.00% decline year-over-year.
- Phoenix Life Sciences International Limited. debt conversion, converted instrument, amount for fiscal 2018 was $74.50K, a 1169.10% increase from fiscal 2017.
- Phoenix Life Sciences International Limited. debt conversion, converted instrument, amount for fiscal 2017 was $5.87K, a 93.91% decline from fiscal 2016.
- Phoenix Life Sciences International Limited. debt conversion, converted instrument, amount for fiscal 2016 was $96.35K, a 150.26% increase from fiscal 2015.
- Phoenix Life Sciences International Limited. debt conversion, converted instrument, amount for fiscal 2015 was $38.50K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2018-11-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-24 | $0.00 derived: sum of 2 quarters · filed 2019-05-24 | $5.28K 10-Q · filed 2019-05-24 | ||
| 2018-08-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-25 | $5.28K 10-Q · filed 2019-04-25 | |||
| 2018-05-31 | $5.28K 10-Q · filed 2019-04-25 | ||||
| 2018-02-28 | $74.50K 10-K · filed 2019-04-22 | ||||
| 2017-02-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-22 | $5.87K 10-K · filed 2019-04-22 | |||
| 2016-11-30 | $5.87K 10-Q · filed 2019-04-19 | ||||
| 2016-02-29 | $42.35K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-09 | $67.35K derived: sum of 2 quarters · filed 2019-04-18 | $67.35K derived: sum of 3 quarters · filed 2019-04-18 | $96.35K 10-K · filed 2019-04-09 | $96.35K 10-K · filed 2019-03-13 |
| 2015-11-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-18 | $25.00K derived: sum of 2 quarters · filed 2019-04-18 | $54.00K 10-Q · filed 2019-04-18 | ||
| 2015-08-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-18 | $29.00K 10-Q · filed 2019-04-18 | |||
| 2015-05-31 | $29.00K 10-Q · filed 2019-04-17 | ||||
| 2015-02-28 | $38.50K 10-K · filed 2019-03-13 |